{
 "url": "https://etfiq.com/funds/kure/holdings/",
 "section": "funds",
 "title": "KURE Holdings: Top 10 and Full List, Nov 11, 2026 | ETFIQ",
 "description": "KURE holdings as of Nov 11, 2026: Beone Medicines Ltd 9.64%, Innovent Biologics Inc 8.14% and Wuxi Biologics Cayman Inc 7.56% and 47 more.",
 "as_of": "Nov 11, 2026",
 "ticker": "KURE",
 "fund": "KraneShares MSCI All China Health Care Index ETF",
 "fund_page": "https://etfiq.com/funds/kure",
 "positions": 50,
 "positions_listed_on_page": 50,
 "lead": "As of Nov 11, 2026, KURE’s top 10 holdings were 54.4% of the fund, led by Beone Medicines Ltd at 9.64%. It held 50 positions.",
 "source": {
  "name": "KraneShares",
  "url": "https://kraneshares.com/csv/11_11_2026_kure_holdings.csv",
  "document": "the issuer’s own daily file",
  "book_date": "2026-11-11",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Beone Medicines Ltd",
   "ticker": "6160 HKG",
   "weight_pct": 9.64,
   "page": "https://etfiq.com/holdings/onc/"
  },
  {
   "rank": 2,
   "holding": "Innovent Biologics Inc",
   "ticker": "1801 HKG",
   "weight_pct": 8.14,
   "page": "https://etfiq.com/holdings/innovent-biologics/"
  },
  {
   "rank": 3,
   "holding": "Wuxi Biologics Cayman Inc",
   "ticker": "2269 HKG",
   "weight_pct": 7.56,
   "page": "https://etfiq.com/holdings/wuxi-biologics-cayman/"
  },
  {
   "rank": 4,
   "holding": "Wuxi Apptec Co Ltd-A",
   "ticker": "603259 SHA",
   "weight_pct": 5.54,
   "page": "https://etfiq.com/holdings/wuxi-apptec-a/"
  },
  {
   "rank": 5,
   "holding": "Jiangsu Hengrui Pharmaceut-A",
   "ticker": "600276 SHA",
   "weight_pct": 4.48,
   "page": "https://etfiq.com/holdings/jiangsu-hengrui-pharmaceuticals-co-ltd/"
  },
  {
   "rank": 6,
   "holding": "Shenzhen Mindray Bio-Medic-A",
   "ticker": "300760 SHE",
   "weight_pct": 4.3,
   "page": "https://etfiq.com/holdings/shenzhen-mindray-bio-medical-electronics-co-ltd/"
  },
  {
   "rank": 7,
   "holding": "Akeso Inc",
   "ticker": "9926 HKG",
   "weight_pct": 4.15,
   "page": "https://etfiq.com/holdings/akeso-inc/"
  },
  {
   "rank": 8,
   "holding": "Sino Biopharmaceutical",
   "ticker": "1177 HKG",
   "weight_pct": 3.91,
   "page": "https://etfiq.com/holdings/sino-biopharmaceutical/"
  },
  {
   "rank": 9,
   "holding": "Cspc Pharmaceutical Group Lt",
   "ticker": "1093 HKG",
   "weight_pct": 3.47,
   "page": "https://etfiq.com/holdings/cspc-pharmaceutical-group-ltd/"
  },
  {
   "rank": 10,
   "holding": "Wuxi Apptec Co Ltd-H",
   "ticker": null,
   "weight_pct": 3.19,
   "page": "https://etfiq.com/holdings/wuxi-apptec-h/"
  },
  {
   "rank": 11,
   "holding": "Hansoh Pharmaceutical Group",
   "ticker": "3692 HKG",
   "weight_pct": 3.09,
   "page": "https://etfiq.com/holdings/hansoh-pharmaceutical-group/"
  },
  {
   "rank": 12,
   "holding": "Genscript Biotech Corp",
   "ticker": "1548 HKG",
   "weight_pct": 2.8,
   "page": "https://etfiq.com/holdings/genscript-biotech-corp/"
  },
  {
   "rank": 13,
   "holding": "Yunnan Baiyao Group Co Ltd-A",
   "ticker": "000538 SHE",
   "weight_pct": 2.42,
   "page": null
  },
  {
   "rank": 14,
   "holding": "Shanghai United Imaging He-A",
   "ticker": "688271 SHA",
   "weight_pct": 2.41,
   "page": "https://etfiq.com/holdings/shanghai-united-imaging-healthcare-co-ltd/"
  },
  {
   "rank": 15,
   "holding": "3SBIO Inc",
   "ticker": "1530 HKG",
   "weight_pct": 2.11,
   "page": "https://etfiq.com/holdings/3sbio-inc/"
  },
  {
   "rank": 16,
   "holding": "Sichuan Kelun-Biotech Biop-H",
   "ticker": "6990 HKG",
   "weight_pct": 2.09,
   "page": "https://etfiq.com/holdings/6990/"
  },
  {
   "rank": 17,
   "holding": "Aier Eye Hospital Group Co-A",
   "ticker": "300015 SHE",
   "weight_pct": 2.02,
   "page": null
  },
  {
   "rank": 18,
   "holding": "Zhangzhou Pientzehuang Pha-A",
   "ticker": "600436 SHA",
   "weight_pct": 1.89,
   "page": null
  },
  {
   "rank": 19,
   "holding": "Sichuan Kelun Pharmaceutic-A",
   "ticker": "002422 SHE",
   "weight_pct": 1.8,
   "page": null
  },
  {
   "rank": 20,
   "holding": "Sichuan Biokin Pharmaceuti-A",
   "ticker": "688506 SHA",
   "weight_pct": 1.72,
   "page": null
  },
  {
   "rank": 21,
   "holding": "Pharmaron Beijing Co Ltd-A",
   "ticker": "300759 SHE",
   "weight_pct": 1.63,
   "page": null
  },
  {
   "rank": 22,
   "holding": "Sinopharm Group Co-H",
   "ticker": "1099 HKG",
   "weight_pct": 1.57,
   "page": "https://etfiq.com/holdings/sinopharm-group-co-ltd/"
  },
  {
   "rank": 23,
   "holding": "Haisco Pharmaceutical Grou-A",
   "ticker": "002653 SHE",
   "weight_pct": 1.31,
   "page": null
  },
  {
   "rank": 24,
   "holding": "Asymchem Laboratories Tian-A",
   "ticker": "002821 SHE",
   "weight_pct": 1.3,
   "page": null
  },
  {
   "rank": 25,
   "holding": "Xtalpi Holdings Ltd",
   "ticker": "2228 HKG",
   "weight_pct": 1.24,
   "page": "https://etfiq.com/holdings/xtalpi-holdings-ltd/"
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "Cash",
   "weight_pct": 0.08
  },
  {
   "holding": "Hong Kong Dollar",
   "weight_pct": 0.07
  },
  {
   "holding": "Cash and other net assets",
   "weight_pct": -0.02
  }
 ],
 "top_10_pct": 54.4,
 "similar_funds": [],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/kure/holdings/kure-holdings.csv",
 "json_book": "https://etfiq.com/data/books/kure.json",
 "markdown": "https://etfiq.com/funds/kure/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Data ETFIQ computes is free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of KURE, data as of Nov 11, 2026. https://etfiq.com/funds/kure/holdings/"
}